STVN - Stevanato Group SpA - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STVN is currently covered by 7 analysts with an average price target of $28.36. This is a potential upside of $4.62 (19.46%) from yesterday's end of day stock price of $23.74.

Stevanato Group SpA's activity chart (see below) currently has 30 price targets and 35 ratings on display. The stock rating distribution of STVN is 70.59% BUY and 29.41% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.24% with an average time for these price targets to be met of 163.71 days.

Highest price target for STVN is $26, Lowest price target is $26, average price target is $32.67.

Most recent stock forecast was given by DERIK DE BRUIN from BAML on 13-Dec-2024. First documented stock forecast 10-Aug-2021.

Currently out of the existing stock ratings of STVN, 12 are a BUY (70.59%), 5 are a HOLD (29.41%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$3.79 (17.06%)

$35

5 months 24 days ago
(13-Dec-2024)

2/3 (66.67%)

$2.69 (11.54%)

206

Hold

$34.5

1 years 7 months 5 days ago
(01-Nov-2023)

2/2 (100%)

$7.76 (29.02%)

347

Buy

$37

$14.79 (66.59%)

$32

1 years 9 months 7 days ago
(30-Aug-2023)

4/5 (80%)

$3.89 (11.75%)

232

Buy

$35

$12.79 (57.59%)

$27

1 years 10 months 6 days ago
(31-Jul-2023)

5/5 (100%)

$3.86 (12.40%)

151

Buy

$23

$8.1 (54.36%)

$26

2 years 6 months 29 days ago
(09-Nov-2022)

1/2 (50%)

$7.19 (44.73%)

24

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STVN (Stevanato Group SpA) average time for price targets to be met?

On average it took 163.71 days on average for the stock forecasts to be realized with a an average price target met ratio 85.24

Which analyst has the current highest performing score on STVN (Stevanato Group SpA) with a proven track record?

PAUL KNIGHT

Which analyst has the current lower performing score on STVN (Stevanato Group SpA) with a proven track record?

DREW RANIERI

Which analyst has the most public recommendations on STVN (Stevanato Group SpA)?

Paul Knight works at KEYBANK and has 8 price targets and 5 ratings on STVN

Which analyst is the currently most bullish on STVN (Stevanato Group SpA)?

Paul Knight with highest potential upside - $14.79

Which analyst is the currently most reserved on STVN (Stevanato Group SpA)?

David Windley with lowest potential downside - -$0

Stevanato Group SpA in the News

Stevanato Group to Participate in Upcoming Investor Conferences

PIOMBINO DESE, Italy, May 09, 2025–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced that it will participate in three upcoming investor conferences. Wednesday, May 14, 2025, at 5:00 p.m. (PT) – Fireside chat at the...

Stevanato Group SpA (STVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

Revenue: Increased by 9% to $256.6 million. Biopharmaceutical and Diagnostic Solutions (BDS) Segment Revenue: Grew 11% to $220.8 million. Engineering Segment Revenue: Decreased by 4% to EUR35.7 million. High-Value Solutions Revenue: Grew 25% to $110.3 million, accounting for 43% of total revenue. Gross Profit Margin: Increased by 80 basis points to 27.2%. Operating Profit Margin:...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?